Trill Impact
Highly Engaged Employees
Highly Engaged EmployeesFinance · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Sveavägen 17 Fl 18, Stockholm, Stockholm...Website
www.trillimpact.comRevenue
$5.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
2
2
1
1
About Trill Impact
Trill Impact is a European private markets firm focused exclusively on impact investments, aiming to deliver attractive financial returns while generating positive social and environmental change. The firm invests in promising entrepreneurs, groundbreaking start-ups, and established businesses through various strategies, including buyouts, ventures, and microfinance. With EUR 1.4 billion in assets under management, Trill Impact seeks to create solutions for a sustainable planet, resilient society, and healthy people. Their philosophy emphasizes innovation and accountability, positioning them as a leading catalyst for positive change.Explore more
Trill Impact Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Trill Impact your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Trill Impact
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Trill Impact has new funding data
Click to see if Trill Impact had a recent Job posting/layoffs
Check if Trill Impact has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Trill Impact launches new products
Website visits: Recent activity has been detected on your website
Trill Impact, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Trill Impact recently announced quarterly report
Check out if Trill Impact is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Trill Impact is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Trill Impact is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Trill Impact.
Trill Impact Tech Stack
A closer look at the technologies used by Trill Impact
Most Recent Scoops
Project
Spending/Investment
Open Position
Project
Spending/Investment
Left Company
Executive Move
Executive Moves, Left Company
Project
Spending/Investment
Trill Impact News & Media
Trill Impact has closed its inaugural Ventures Fund, focusing on improved health and climate action
The closing enables continued growth for Trill Impact’s Ventures portfolio, backing innovative companies addressing the health and environmental challenges of tomorrow. Trill Impact was founded in 2019 and has since then raised above EUR 1.3 billion in assets under management across its three strategies: Impact Private Equity, Impact Ventures and Microfinance. The inaugural Ventures Fund has closed on above EUR 90 million with a thematic focus primarily on Life Science and Green Technology invesTrading in Trill Impact’s portfolio company Cinclus Pharma commences on Nasdaq Stockholm
The Swedish biopharmaceutical company has successfully raised capital for Phase 3 clinical development Cinclus Pharma Holding AB (publ) (“Cinclus Pharma”) is a Swedish late-stage pharmaceutical company committed to improving the medical outcomes for patients suffering from severe stomach acid-related disorders worldwide. The company is targeting two main clinical indications; GERD (Gastroesophageal reflux disease) and H. pylori infection. Cinclus Pharmas’ drug candidate, linaprazan glurate, is aMay Health Raises $25 Million in Series B Funding to Advance Development for Ovarian Rebalancing Therapy
PARIS--(BUSINESS WIRE)--May Health, a clinical-stage medical device company dedicated to helping those living with the endocrine disorder polycystic ovary syndrome (PCOS), today announced it has closed a $25 million Series B financing round, co-led by Bpifrance and Trill Impact with participation from founding investor Sofinnova Partners, as well as Avestria Ventures and Kidron Capital Assets LP. Funds will be used to support the company’s growth and advance its Ovarian Rebalancing™ therapy thrTrill Impact Ventures co-leads USD 25 million series B financing round in May Health
Advancing novel treatment for women suffering from Polycystic Ovary Syndrome related infertility. Trill Impact Ventures, announces that it together with Bpifrance, has co-led a USD 25m series B financing round in May Health, a French-American medical device company targeting Polycystic Ovary Syndrome (PCOS) related infertility. The round also saw participation from existing May Health investor Sofinnova Partners. Proceeds will advance the clinical development of May Health’s innovative device, a
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Trill Impact
Sign Up For FreeTo access detailed company insights
Trill Impact is a European private markets firm focused exclusively on impact investments, aiming to deliver attractive financial returns while generating positive social and environmental change. The firm invests in promising entrepreneurs, groundbreaking start-ups, and established businesses through various strategies, including buyouts, ventures... Read More
